Editorial
Copyright ©The Author(s) 2024.
World J Gastroenterol. Sep 28, 2024; 30(36): 4036-4043
Published online Sep 28, 2024. doi: 10.3748/wjg.v30.i36.4036
Figure 2
Figure 2 Glucagon-like peptide-1 receptor agonists improve ovarian dysfunction in a mouse model of polycystic ovary syndrome. GLP-1RA: Glucagon-like peptide-1 receptor agonists; GLP-1: Glucagon-like peptide-1; PCOS: Polycystic ovary syndrome; DFMA: Difluoro methylarginine.